Aytu Biopharma (AYTU) EBT Margin (2013 - 2026)
Aytu Biopharma (AYTU) recorded EBT Margin of -0.02% in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 128.44 percentage points from -128.46% a year earlier and up 45.16 percentage points from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) EBT Margin (2013 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma reported EBT Margin of -24.72%, down 4.01 percentage points from FY2025.
- Annual EBT Margin has declined for three straight fiscal years, though with a five-year change of +63.70 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, EBT Margin came in at -20.71% in FY2025 (-4.78 pp), -15.92% in FY2024 (-0.05 pp), -15.88% in FY2023 (+96.76 pp) and -112.64% in FY2022 (-24.22 pp).
- Quarterly EBT Margin has ranged from -220.22% in fiscal Q3 2022 to 20.69% in fiscal Q3 2025 over the past five years.
- On a year-over-year basis, EBT Margin rose in four of the last eight quarters, with an average year-over-year change of -4.55 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 188.55 percentage points in fiscal Q3 2023, against a drop of 111.08 percentage points in fiscal Q4 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -45.19% (Q3 2026), -69.79% (Q2 2026) and 14.15% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Aytu Biopharma | 23.58 Mn | -92.10 Mn | 10.41 Mn | -0.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02% |
| Mar 31, 2026 | -45.19% |
| Dec 31, 2025 | -69.79% |
| Sep 30, 2025 | 14.15% |
| Jun 30, 2025 | -128.46% |
| Mar 31, 2025 | 20.69% |
| Dec 31, 2024 | 2.35% |
| Sep 30, 2024 | 9.04% |
| Jun 30, 2024 | -17.39% |
| Mar 31, 2024 | -12.60% |
| Dec 31, 2023 | 7.46% |
| Sep 30, 2023 | -41.94% |
| Jun 30, 2023 | -7.99% |
| Mar 31, 2023 | -31.67% |
| Dec 31, 2022 | -25.47% |
| Sep 30, 2022 | -2.53% |
| Jun 30, 2022 | -58.62% |
| Mar 31, 2022 | -220.22% |
| Dec 31, 2021 | -49.95% |
| Sep 30, 2021 | -127.68% |
API Access
Aytu Biopharma EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();